Saccharomyces Boulardii, a friendly yeast with no side effects, will be the treatment in the majority of cases.

Sacchromyces Boullardi is a friendly, Non-Pathogenic, yeast which acts as a biotherapeutic agent. Controlled clinical trials have demonstrated the efficacy of Saccromyces Boullardi for preventing or treating several intestinal disorders including:

• AAD - antibiotic associated diarrhea
• C difficile
• enterocolopathies
• acute gastroenteritis
• traveler's diarrhea
• Irritable Bowel Syndrome

In the journal Alimentary Pharmacology and Therapeutics, 1-MAR-2005; 21(5): 583-90

M. Kotowska, et al., studied...

“Saccharomyces boulardii in the prevention of antibiotic-associated diarrhoea in children: a randomized double-blind placebo-controlled trial.”

CONCLUSION: This is the first randomized-controlled trial evidence that S. boulardii effectively reduces the risk of antibiotic-associated diarrhoea in children.

In the Journal of Tropical Pediatrics,  01-AUG-2004; 50(4): 234-6

O Erdeve, et al., studied

“The probiotic effect of Saccharomyces boulardii in a pediatric age group.”

The aim of this study was to determine the efficacy of S. boulardii in diarrhea associated with commonly used antibiotics...

...In the group receiving SAM [sulbactam-ampicillin] where S. boulardii use was found to be significant, the use of S. boulardii decreased the diarrhea rate from 32.3 to 11.4 per cent in the 1-5 years age group (p < 0.05). This is a pioneering study investigating combined antibiotic and probiotic use in pediatric diarrhea patients.

Natural Pharmaceuticals SHOULD BE TAKEN UNDER MEDICAL SUPERVISION, WITH MEDICAL TESTING TO ENSURE THAT MEDICAL GOALS ARE BEING REACHED.